$21.74
Price
$291M
Market Cap
—
P/E Ratio
22.9
Forward P/E
$-0.22
EPS (TTM)
—
Dividend Yield
$38M
Cash
$26M
Total Debt
13M
Shares Out
$8.22
$22.88
52-Week Range
Institutional Ownership of Anika Therapeutics Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Anika Therapeutics Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2019-Q1 | |||||
| SELL | EXIT | — | — | $34.09 | |
| 2018-Q4 | |||||
| SELL | -3.1% | 374.9K | $13M | $35.55 | |
| 2018-Q3 | |||||
| BUY | +47.4% | 386.9K | $16M | $41.22 | |
| 2018-Q2 | |||||
| BUY | NEW | 262.5K | $8M | $42.45 | |
Insider Trading for Anika Therapeutics Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.